Cathy Kacmarzyk

Cathy Kacmarzyk is a seasoned professional with extensive experience in the pharmaceutical industry, currently serving as a Clinical Account Executive for Rare Disease at ANI Pharmaceuticals, Inc. since October 2022, where responsibilities include promoting Purified Cortrophin Gel to various specialists and managing complex reimbursement processes. Previous roles include Area Business Manager for Biologics at Sanofi, successfully overseeing Dupixent promotions, and Musculoskeletal Business Manager at Flexion Therapeutics, focusing on the launch of Zilretta. Cathy has a strong background in sales and reimbursement management, having held several managerial positions at Sanofi Genzyme, where duties involved effective promotions of Synvisc One and leading sales teams across multiple states. Cathy began their career at Neurocrine Biosciences and GlaxoSmithKline, contributing to the promotion of a range of pharmaceutical products across various therapeutic areas. Cathy holds a Bachelor of Arts in Psychology from Wayne State University.